Valuation: Celltrion, Inc.

Market Cap 42,104B 27.51B 24.05B 22.1B 20.6B 39.07B 2,619B 39.66B 265B 103B 1,287B 103B 101B 4,437B P/E 2026 *
30.5x
P/E 2027 * 25.3x
Enterprise Value 44.29B 28.93M 25.29M 23.25M 21.67M 41.1M 2.75B 41.72M 279M 108M 1.35B 109M 106M 4.67B EV / Sales 2026 *
8.33x
EV / Sales 2027 * 7.05x
Free-Float
58.37%
Yield 2026 *
0.41%
Yield 2027 * 0.43%
1 day+3.96%
1 week+10.67%
Current month+5.94%
1 month+4.02%
3 months-1.29%
6 months-4.80%
Current year+6.51%
1 week 167,900
Extreme 167900
188,000
1 month 158,500
Extreme 158500
188,000
Current year 158,500
Extreme 158500
239,047.62
1 year 158,500
Extreme 158500
239,047.62
3 years 114,250.83
Extreme 114250.8285
239,047.62
5 years 114,250.83
Extreme 114250.8285
247,058.06
10 years 64,487.59
Extreme 64487.5934
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 20/03/2015
Chief Executive Officer 42 26/03/2021
President 50 13/02/2026
Director TitleAgeSince
Chairman 68 -
Director/Board Member 61 01/04/2005
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap.
01-16Sell 500 0.0002%
01-16Sell 1,000 0.0004%
01-16Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+3.96%+10.67%+8.30%+40.44% 27.51B
+1.70%+7.41%+2.50%+8.22% 49.92B
+0.92%+3.93%+399.71%+605.33% 40.23B
+1.89%+8.32%+26.06%-6.35% 34.55B
+2.38%+6.35%+21.25%+64.58% 33.09B
+2.51%+5.27% - - 17.05B
+2.58%+5.79%+73.44%+133.27% 15.92B
+0.32%+0.58%+14.00%+19.59% 13.86B
+3.30%+0.76%+90.23%+99.12% 13.52B
+5.63%+59.76%+1,820.34%+785.83% 13.31B
Average +2.52%+11.22%+272.87%+194.45% 25.9B
Weighted average by Cap. +2.25%+9.27%+185.40%+173.56%

Financials

2026 *2027 *
Net sales 5,319B 3.47B 3.04B 2.79B 2.6B 4.94B 331B 5.01B 33.51B 13.03B 163B 13.04B 12.76B 560B 6,171B 4.03B 3.52B 3.24B 3.02B 5.73B 384B 5.81B 38.89B 15.12B 189B 15.13B 14.81B 650B
Net income 1,400B 915M 800M 735M 685M 1.3B 87.11B 1.32B 8.82B 3.43B 42.82B 3.43B 3.36B 148B 1,690B 1.1B 965M 887M 827M 1.57B 105B 1.59B 10.65B 4.14B 51.69B 4.15B 4.06B 178B
Net Debt 2,182B 1.43B 1.25B 1.15B 1.07B 2.02B 136B 2.06B 13.75B 5.34B 66.71B 5.35B 5.24B 230B 1,428B 933M 816M 749M 699M 1.33B 88.83B 1.35B 9B 3.5B 43.66B 3.5B 3.43B 150B
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,680
Date Price Change Volume
03/07/26 ₩183,600.00 +3.96% 853,838
02/07/26 ₩176,600.00 +1.20% 712,765
01/07/26 ₩174,500.00 +0.69% 473,079
30/06/26 ₩173,300.00 -3.29% 565,686
29/06/26 ₩179,200.00 +8.02% 765,680
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
183,600.00KRW
Average target price
255,593.25KRW
Spread / Average Target
+39.21%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A068270 Stock